tbuckley/cabot-search huggingface dataset:
Undetectable MRD Status in Patients with R/R CLL/SLL with Stable Disease after Lisocabtagene Maraleucel Treatment: Exploratory Analysis of the TRANSCEND CLL 004 Study
Authors: Eniko Papp, Sahar Ansari, Jason Wall, Ethan Thompson, Yizhe Chen, Tanya Siddiqi, William G. Wierda, Serena K. Perna, Sherilyn A. Tuazon, Abood Okal, Leanne Peiser
Journal: Blood (2023)
HMGA1 Chromatin Regulators Drive Immune Evasion in MPN Progression through Epigenetic Rewiring to Repress Antigen Presentation
Authors: Joseph Kim, Audrey-Ann Supreme, Bailey West, Mariah C. Antopia, Karen Reddy, Leslie Cope, Jung-Hyun Kim, Raajit K. Rampal, Richard Koche, Jerry L. Spivak, Alison R. Moliterno, Linda Resar
Journal: Blood (2023)
Roxyscan: A Novel Method to Assess Red Blood Cell Resilience to Oxidative Stress in Sickle Cell Disease
Authors: Carolina A. Hernandez, Marissa J.M. Traets, Myrthe J. van Dijk, Wouter W. van Solinge, Frans A. Kuypers, Minke A.E. Rab, Eduard J. Van Beers, Richard van Wijk
Journal: Blood (2023)
A Phase 2b Study of Selinexor in Combination with Carfilzomib, Daratumumab, or Pomalidomide in Patients with Multiple Myeloma Relapsing on Current Therapy
Authors: Noa Biran, David H. Vesole, Harsh Parmar, Pooja Phull, Kimberly Doucette, Rena Feinman, Joshua Zenreich, Palka Anand, Kristin Ivanovski, Monique Pace, Lisa Biamonte, Martha Campanaro, Trina McClendon, Chandani Limbad, Samanta BaboolallAracena, Adolfo Aleman, Rashmi Unawane, Elizabeth Pendergrass, Marie Layton, Genevieve Breeze, Aimee Chappell, Alexandra Della Pia, Susan Kumka, David S. Siegel
Journal: Blood (2023)
Multi-Omics Exploration of Adaptive Mechanism to BTK Inhibition By Ibrutinib in CLL Identified TMBIM6/BI-1 As a Poor Prognosis Variable and Potential Therapeutic Target
Authors: Daniel Medina, Laura Palomo, Víctor Navarro, Oriol Castells, Belén Sánchez, Pau Marc Muñoz Torres, Carlota Pagès Geli, Cristina Hernández, Gemma Pujadas, Alba Cabirta Touzón, Christelle Ferrà, Miguel Alcoceba, María José Terol, Rafael Andreu, Francesc Bosch, Pau Abrisqueta, Marta Crespo
Journal: Blood (2023)
Hemostasis Biomarkers and Long-Term Risk of Recurrent Cardiovascular Events and Bleeding Complications in Young Patients with an Ischemic Stroke
Authors: Janneke Spiegelenberg, Mark Roest, Bas De Laat, Marleen van Gelder, Saskia Middeldorp, Anil Tuladhar, Jenneke Leentjens, Frank-Erik De Leeuw
Journal: Blood (2023)
A Phase (Ph) 2 Study of TL-895, a Highly Selective, Novel Covalent BTK Inhibitor (BTKi), in Patients (pts) with Treatment-Naïve (TN) and Relapsed/Refractory (R/R) BTKi-Naïve Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
Authors: John C. Byrd, Dariusz Woszczyk, Arpad Illes, Wojciech Jurczak, Dominik Chraniuk, Krzysztof Giannopoulos, Nataliia Mikhailova, Peter Illconzai, Seema A Bhat, Nataliya Romanyuk, Ganna Usenko, Olha Kuchkova, Jason Chandler, Elizabeth Bilotti, Annalise Shen, Jean Cheung, Srdan Verstovsek, Jesse McGreivy, Wayne Rothbaum, Maciej Kaźmierczak
Journal: Blood (2023)
Fertility and Parenthood in Patients with Acute Promyelocytic Leukemia Treated with Arsenic Trioxide and All-Trans Retinoic Acid
Authors: Charanpreet Singh, Manpreet Saini, Arihant Jain, Deepesh Pravinkumar Lad, Gaurav Prakash, Alka Rani Khadwal, Shano Naseem, Pankaj Malhotra
Journal: Blood (2023)
Impact of a Trampoline-Based Exercise Program on Strength and Endurance in Pediatric Stem Cell Transplant Patients
Authors: Pia Glogowski, Léa Thérond, Tobias Giebler, Stefanie Thiel, Johanna Sophie Xemaire, Christian Martin Seitz, Johannes Schulte, Peter Lang, Rupert Handgretinger, Karin Melanie Cabanillas Stanchi, Michaela Döring
Journal: Blood (2023)
Hematological Toxicity of Immune Checkpoint Inhibitors: Real-World Retrospective Outcomes from a Cohort Study in Qatar
Authors: Maria Benkhadra, Shereen Elazzazy, Anas Ahmad Hamad, Mohamed S. Elkhatim, Amaal Gulied, Arwa Osama Sahal, Aya Alasmar, Farah I. Jibril, Hebatalla Mahmoud Afifi, Sahar Nasser, Afnan Alnajjar, Rawan Dawoud, Nabil E. Omar
Journal: Blood (2023)
When I use a word . . . Medicines regulation—Patent medicines
Authors: Jeffrey K Aronson
Journal: BMJ (2023)

“Patent” means open. Letters patent are government documents that grant the sole right to make, use, or sell some commodity, such as a medicine. The UK’s 1868 Pharmacy Act made it an offence for anyone other than a registered pharmaceutical chemist or chemist and druggist to sell poisons. Furthermore, such an individual was required to conform to certain regulations, such as indicating the poisonous nature of the formulation on the label. However, section 16 of the act exempted medicines that, although called “patent medicines,” were not actually protected by a government patent. Nevertheless, in 1892, a magistrate defined a patent medicine as one that had a government patent, and thus all so-called patent medicines that were not patented came under the 1868 Pharmacy Act, with the requirements of which those who sold such medicines had to comply. What was once secret became open.
Itacitinib for the Prevention of Immune Effector Cell Therapy-Associated Cytokine Release Syndrome: Results from the Phase 2 Incb 39110-211 Placebo-Controlled Randomized Cohort
Authors: Matthew J. Frigault, Richard T Maziarz, Jae H. Park, Aleksandr Lazaryan, Nirav N. Shah, Jakub Svoboda, Lazaros J. Lekakis, Ran Reshef, Christine L Phillips, Lea M Burke, Jing Lei, Rodica Morariu-Zamfir, John F. DiPersio
Journal: Blood (2023)
Sequential Chemotherapy and Blinatumomab to Improve Minimal Residual Disease in Adult Ph- B-Lineage Acute Lymphoblastic Leukemia. Final Results of the Phase II Gimema LAL2317 Trial
Authors: Sabina Chiaretti, Irene Della Starza, Alessandra Santoro, Orietta Spinelli, Loredana Elia, Maria Stefania De Propris, Matteo Piccini, Patrizia Chiusolo, Felicetto Ferrara, Patrizia Zappasodi, Erika Borlenghi, Catello Califano, Monica Bocchia, Elisa Mauro, Fabrizio Pane, Anna Candoni, Albana Lico, Ernesta Audisio, Monia Lunghi, Anna Maria Mianulli, Mariangela Di Trani, Valentina Arena, Monica Messina, Alfonso Piciocchi, Paola Fazi, Alessandro Rambaldi, Robin Foà, Renato Bassan
Journal: Blood (2023)
Ancestry-Specific Genetic Determinants of Clonal Haematopoiesis: A Comparative Analysis of 136,401 Admixed Americans and 419,228 Europeans
Authors: Sean Wen, Fengyuan Hu, Abhishek Nag, Ioanna Tachmazidou, Sri Vishnu Vardhan Deevi, Haeyam Taiy, Katherine Smith, Keren Carss, Sebastian Wasilewski, Jesus Alegre-Díaz, Pablo Kuri-Morales, Jaime Berumen, Roberto Tapia-Conyer, Jonathan Emberson, Jason M. Torres, Rory Collins, Quanli Wang, Slavé Petrovski, Margarete Fabre, Andrew Harper, George Vassiliou, Jonathan Mitchell
Journal: Blood (2023)
Intestinal Epithelial-Derived IL-34 Regulates Macrophage Polarization in an Apolipoprotein E Dependent Manner and Mitigates the Severity of Graft Versus Host Disease
Authors: Aditiya Rayasam, Alison Moe, Ravi Shah, Cheng-Yin Yuan, Marco Colonna, James Miller, Anthony Zamora, William Drobyski
Journal: Blood (2023)
Patient-Reported Outcome Measures Associated with Overall Survival and Acute Care Use in Patients with Newly Diagnosed Myelodysplastic Syndrome, Acute Myelogenous Leukemia, or Acute Lymphoblastic Leukemia
Authors: Seiichi Villalona, Xin Wang, Peter Gabriel, Abigail Doucette, Shannon R McCurdy, Alexander Perl, Selina M Luger, Noelle V. Frey, Ximena Jordan Bruno, Elizabeth O Hexner, Daria V Babushok, David L. Porter, Alison W Loren, Keith W Pratz, Catherine Lai
Journal: Blood (2023)
Olverembatinib Combined with Venetoclax and Reduced-Intensity Chemotherapy for Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Early Results from a Phase II Study
Authors: Xiaoyuan Gong, Qiuyun Fang, Runxia Gu, Shaowei Qiu, Kaiqi Liu, Dong Lin, Chunlin Zhou, Guangji Zhang, Benfa Gong, Yuntao Liu, Shuning Wei, Yan Li, Shouyun Li, Bingcheng Liu, Yimin Hu, Junfan Li, Ying Wang, Hui Wei, Yingchang Mi, Jianxiang Wang
Journal: Blood (2023)
Attrition after Referral for Chimeric Antigen Receptor T-Cell (CAR-T) Products in Multiple Myeloma (MM)
Authors: Naveen Subramanian, Ashwath Gurumurthi, Oren Pasvolsky, Christopher Ferreri, Hans C. Lee, Elisabet E. Manasanch, Sheeba K. Thomas, Donna M. Weber, Mahmoud Gaballa, Christen Dillard, Melody Becnel, Chitra Hosing, Pei Lin, Behrang Amini, Muzaffar H. Qazilbash, Nilesh Kalariya, Misha Hawkins, Sairah Ahmed, Robert Z. Orlowski, Krina K. Patel
Journal: Blood (2023)
Antigen Receptor Gene Repertoire Profiling in Kidney Transplant Recipients Post-Sars-Cov-2 Vaccination
Authors: Antonios Mingos, Nikolaos Pechlivanis, Georgios Karakatsoulis, Glykeria Gkoliou, Nikolaos Vastarouchas, Smaragdi Marinaki, Paraskevi Tsoutsoura, Myrto Papamentzelopoulou, Vassiliki Pitiriga, Mina Psichogiou, Angelos Hatzakis, Kostas Stamatopoulos, Elisavet Vlachonikola, Anastasia Chatzidimitriou
Journal: Blood (2023)
Single-Cell Multi-Omics Reveals Type-2 Functionality in Maintaining CAR T Cell Longevity Associated with 8-Year Leukemia Remission
Authors: Zhiliang Bai, Bing Feng, Susan E. Mcclory, Caroline Diorio, Ziran Zhao, Li Tang, J. Joseph Melenhorst, Carl June, Stephan Grupp, Rong Fan
Journal: Blood (2023)
The Impact of Air Pollutants on a Chicagoland Cohort of Patients with Acute Myeloid Leukemia
Authors: Andrew Palmer, Garth Rauscher, Ivy Abraham, Madelyn Burkart, Ami Dave, Nepheli Raptis, Ahmed Aleem, Vedavyas Gannamani, Amani Erra, Sarah Monick, Carlos Galvez, Melissa L. Larson, Maryam Zia, Stephanie B. Tsai, Jessica K. Altman, Wendy Stock, Irum Khan, Anand Ashwin Patel
Journal: Blood (2023)
A Study to Evaluate the Effectiveness and Safety of Prephase Steroid Treatment before Remission Induction Chemotherapy in Patients with Pediatric Acute Lymphoblastic Leukemia Using Common Data Model-Based Real World Data
Authors: Yoona Choi, Bo Kyung Kim, Jae Won Yoo, Wona Choi, Jung-Hyun Won, Surin Jung, Jae Yoon Kim, In Young Choi, Nack-Gyun Chung, Jae Wook Lee, Hyoung Jin Kang, Howard Lee
Journal: Blood (2023)
Early Prediction of Treatment Response By Circulating Tumor DNA Profiling in Patients with Diffuse Large B-Cell Lymphoma Receiving CAR T-Cell Therapy
Authors: Anna Katharina Foerster, Corinna Kronenthaler, Lavanya Ranganathan, Samuel Bandara, Corinna Woestmann, Stephanie Yaung, Sabine Bleul, Christian Klingler, Jan Mitschke, Julius Wehrle, Ralph Wäsch, Justus Duyster, Tim Struessmann, Jürgen Finke, Bowdoin Su, Reinhard Marks, Florian Scherer
Journal: Blood (2023)
Genomic and Transcriptomic Profiles of Blastoid and Pleomorphic Mantle Cell Lymphoma Are Distinct from Classic Histology Mantle Cell Lymphoma
Authors: Preetesh Jain, Holly A Hill, Chi Young Ok, Alexander Nesmalov, Vitaly Segodin, Dmitry Tabakov, Nikita Kotlov, Pavel Zemskiy, Eleonora Belykh, Krystle Nomie, Ahmed Fetooh, Rashmi Kanagal-Shamanna, Fatima Z Jelloul, Guilin Tang, Francisco Vega, Nathan Fowler, Christopher R. Flowers, Michael L. Wang
Journal: Blood (2023)
Total Therapy (TT)-4: A Phase 3 Trial Comparing L-TT4 and S-TT4 and Tandem Auto Transplants in Standard Risk Multiple Myeloma
Authors: Samer Al Hadidi, Obada Ababneh, Carson W Ercanbrack, Carolina Schinke, Sharmilan Thanendrarajan, Clyde Bailey, Robert Smith, Susan Panozzo, Guido Tricot, Daisy V. Alapat, John D Shaughnessy, Jr, Fenghuang Zhan, Bart Barlogie, Maurizio Zangari, Frits van Rhee
Journal: Blood (2023)
Mezigdomide Treatment in Relapsed-Refractory Myeloma Patients Shifts Bone Marrow NK and T Cell Populations from Exhaustion to Activation
Authors: Lucia Y Chen, Oliver Van Oekelen, Michael Amatangelo, Tracy T. Chow, Bhaskar Upadhyaya, Alessandro Lagana, Geoffrey Kelly, Seunghee Kim-Schulze, Adolfo Aleman, Antonina Kurtova, Sarah Gooding, Sundar Jagannath, Erin Flynt, Anita K. Gandhi, Udo Oppermann, Anjan Thakurta, Samir Parekh
Journal: Blood (2023)
LGL in MGUS or MGUS in LGL? Lessons of Nature and Their Clinical Implications
Authors: Carlos Bravo-Perez, Carmelo Gurnari, Naomi Kawashima, Danai Dima, Olisaemeka Ogbue, Luca Guarnera, Yasuo Kubota, Nakisha D Williams, Arooj Ahmed, Fauzia Ullah, Arda Durmaz, Megan Nakashima, Valeria Visconte, Jaroslaw P. Maciejewski
Journal: Blood (2023)
Effect of Luspatercept on Erythropoiesis and Fetal Hemoglobin in β-Transfusion-Dependent Thalassemia Patients: A Real-Life Experience
Authors: Daniele Lello Panzieri, Guido Ausenda, Francesca Granata, Nancy Caponio, Dario Consonni, Lorena Duca, Elena Cassinerio, Silvia Elli, Marta Ferraresi, Giovanna Graziadei, Simona Leoni, Natalia Scaramellini, Valentina Brancaleoni, Maria Domenica Cappellini, Irene Motta
Journal: Blood (2023)
Retrospective Observational Study on Real-World Bortezomib Prescribing Patterns and Outcomes in Newly Diagnosed Multiple Myeloma
Authors: Fieke W Hoff, Rahul Banerjee, Adeel Khan, Georgia McCaughan, Xiaoliang (Wendy) Wang, James Roose, Larry D. Anderson, Andrew J. Cowan, Vincent Rajkumar, Gurbakhash Kaur
Journal: Blood (2023)
<i>No Improvement in the Age Adjusted Mortality of Older Adults with Acute Lymphoblastic Leukemia Despite the Availability of Blinatumumab, Inotuzumab and Novel TKIs : A 1999-2020 Analysis in the United States</i>
Authors: Tony Varughese, Maciej Kabat, Eli Zolotov, Jamie Koprivnikar
Journal: Blood (2023)
Predictors and Timing of Venous Thromboembolism in Lymphoma
Authors: Asaad Trabolsi, Thomas Plate, Rachel S. Kronenfeld, Leticia E. Campoverde, Dan Morgenstern Kaplan, Alyssa Mercadel, Michael Caballero, Wei Zhao, Izidore S. Lossos, Craig H. Moskowitz, Gerald A. Soff
Journal: Blood (2023)
Influence of Bone Marrow Blast Enumeration and Co-Occurring Myelodysplasia Related Gene Mutations in <i>NPM1</i>-Mutated Myeloid Malignancies
Authors: Curtis A Lachowiez, Georgios Asimomitis, Elsa Bernard, Ivory Tang, Yanis Tazi, Amanda Gilkes, Ian Thomas, Lars Bullinger, Konstanze Döhner, Hartmut Dohner, Brian Huntly, Nigel H. Russell, Sanam Loghavi, Elli Papaemmanuil
Journal: Blood (2023)
Population Pharmacokinetics and Exposure-Response Analyses to Demonstrate the Link of Causality between ADAMTS13 and the Clinical Effects of Recombinant ADAMTS13 Compared to Plasma-Based Therapies
Authors: Munjal Patel, Olivier Barriere, Paul Diderichsen, Huijuan Xu, Andy Zhu, Jean François Marier, Björn Mellgård, Wenping Wang, Indranil Bhattacharya
Journal: Blood (2023)
The Impact of Isatuximab Regimens on Hypogammaglobulinemia Occurrence, Recovery, and Associated Infections in Patients with Relapsed/Refractory Multiple Myeloma
Authors: Cesar Rodriguez, Aurore Perrot, Paul G. Richardson, Thierry Facon, Ivan Spicka, Albert Oriol, Kenshi Suzuki, Edvan Crusoe, Ajai Chari, Nicole Armstrong, Christina Tekle, Marie-Laure Risse, Thomas Martin, Philippe Moreau
Journal: Blood (2023)
External Validation of PRISM Score in Multiple Myeloma Patients in a Community Setting: A Retrospective Cohort Study
Authors: Abinesh Sekar, Chidambaram Ramasamy, Harinivaas Shanmugavel Geetha, Madhan Srinivasan Kumar, Masood Pasha Syed, Kala Seetharaman, George M. Abraham
Journal: Blood (2023)
DA-EPOCH-R for High Grade B-Cell Lymphoma Patients with MYC and BCL2 and/or BCL6 Rearrangements: Clinical Results of the Induction Phase of the HOVON-152 Trial
Authors: A.Vera de Jonge, Marie José Kersten, Erik van Werkhoven, Marjolein van der Poel, Koen de Heer, Clara Klerk, Yorick Sandberg, Rozemarijn S Van Rijn, Rob Fijnheer, Pim Mutsaers, Vibeke Vergote, Djamila Issa, Aart Beeker, Yavuz M. Bilgin, Lara H. Böhmer, Laurens Nieuwenhuizen, Wendy Stevens, Roel JW van Kampen, Rogier Mous, Marc Durian, Tjeerd Snijders, Joost S.P Vermaat, Otto Visser, Josée M. Zijlstra, Henk Hofwegen, Helma G.J.M. Zanders, Liping P. Fu, Daphne De Jong, Marcel Nijland, Martine E.D. Chamuleau
Journal: Blood (2023)
Epcoritamab SC + GemOx Leads to High Complete Metabolic Response Rates in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Ineligible for Autologous Stem Cell Transplant: Updated Results from Epcore NHL-2
Authors: Joshua Brody, Judit Mészáros Joergensen, David Belada, Regis T. Costello, Marek Trněný, Umberto Vitolo, David Lewis, Yasmin H. Karimi, Anna Maria Sureda Balari, Marc André, Björn E. Wahlin, Pieternella Lugtenburg, Faith Galderisi, Aqeel Abbas, Yaou Song, Malene Risum, Raul Cordoba
Journal: Blood (2023)
Quantum-First (Q-F): Clinical Bridging Study for FMS-like Tyrosine Kinase 3-Internal Tandem Duplication ( <i>FLT3</i>-ITD) Companion Diagnostic Development
Authors: Jaime E Rohrbach, Ken C N Chang, Maha Karnoub, Li Liu, Yasser Mostafa Kamel, Shirin Khambata-Ford, Shawn Rivera, Jelveh Lameh, Ekaterina Rudenko, Jordan Thornes, Sarah Todt, Jason Gerhold, Ying Huang, Jeffrey E Miller, Alexander Perl, Mark J. Levis, Kazumi Ito
Journal: Blood (2023)
Tranexamic Acid for Trauma Care: An Updated Meta-Analysis of Mortality and Thromboembolic Events in Severely Injured Patients
Authors: Nouman Shafique, Usman Ali Akbar, Ahmed Muaaz Umer, Besham Kumar, Fnu Muhibullah, Fakeha Siddiqui, Sindhu Vikash, Sanjana Nethagani, Umer Rizwan
Journal: Blood (2023)
Discovery of BT-114143, a Novel and Potent Small-Molecule Plasminogen Inhibitor for Hyperfibrinolysis
Authors: Jun Tang, Sen Ji, Xiao Hu, Yan Wang, Jun Qi, Xiao Wang, Hao Wang, Jianzong Li, Zhiqiang Li, Min Li, Shaomei Zeng, Xiong Yuan, Xiaodong Zhang
Journal: Blood (2023)
Use of Combination Premedication Prior to Motixafortide Administration Reduced Severity and Frequency of AEs in the Phase 3 Genesis Trial - a Single Center Analysis
Authors: Zachary David Crees, Keith Stockerl-Goldstein, Mark A. Schroeder, Ravi Vij, Ella Sorani, Irit Gliko Kabir, Inbal Goldstein, Tzipi Lustig, Shaul Kadosh, John F. DiPersio
Journal: Blood (2023)
Impact of Symptom Benefit and Transfusion Response on Survival in Myelofibrosis Patients Treated with Pacritinib: PERSIST-2 Landmark Survival Analysis
Authors: Helen Ajufo, Jan Philipp Bewersdorf, Claire N Harrison, Francesca Palandri, John Mascarenhas, Jeanne Palmer, Aaron T. Gerds, Jean-Jacques Kiladjian, Sarah Buckley, Andriy Derkach, Karisse Roman-Torres, Raajit K. Rampal
Journal: Blood (2023)
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma (Glo-BNHL)
Authors: Emma Seaford, Shanna Maycock, Sarah Alexander, Auke Beishuizen, Birte Wistinghausen, Veronique Minard-Colin, Charlotte Rigaud, Charles A Phillips, James B. Ford, Pamela R. Kearns, Anna Lawson, Ellie Williams, Zahra Ahmed, Mahnoor Muzaffar, Rhianna Parsons, Lia Gore, Nicole Scobie, Victoria Buenger, Carl Allen, Karin Mellgren, Catherine M. Bollard, Anne Auperin, Lucinda Billingham, Gladstone Austin Amos Burke
Journal: Blood (2023)
Expanded Assessments of Germline Genetic Variants Identify Additional Risk Loci for Langerhans Cell Histiocytosis
Authors: Erin Peckham-Gregory, Priya Bhatia Shetty, Erik Stricker, Danielle Mitchell, Howard Lin, Brooks Scull, Erik Ehli, Christel Davis, Kenneth L. McClain, Philip J. Lupo, Carl E Allen, Michael E. Scheurer
Journal: Blood (2023)
Combined Ibrutinib and Venetoclax for First-Line Treatment of Patients with Chronic Lymphocytic Leukemia (CLL): 5-Year Follow-up Data
Authors: Nitin Jain, Michael J. Keating, Philip A. Thompson, Alessandra Ferrajoli, Jayastu Senapati, Jan A. Burger, Gautam Borthakur, Mahesh Swaminathan, Koichi Takahashi, Zeev Estrov, Marina Y. Konopleva, Koji Sasaki, Tapan M. Kadia, Naveen Pemmaraju, Naval Daver, Elias Jabbour, Courtney D. DiNardo, Yesid Alvarado Valero, Musa Yilmaz, Prithviraj Bose, Maro Ohanian, Rashmi Kanagal-Shamanna, Keyur Patel, Jeffrey L. Jorgensen, Sa A. Wang, Sameh Nassar, Naveen Garg, Hyunsoo Hwang, Xuemei Wang, Nichole Cruz, Ana Ayala, William Plunkett, Hagop M. Kantarjian, Varsha Gandhi, William G. Wierda
Journal: Blood (2023)
Three-Year Interim Analysis Results of the AOZORA Study to Evaluate the Long-Term Safety and Joint Health in Children with Hemophilia A without Factor VIII Inhibitors Receiving Emicizumab
Authors: Midori Shima, Hideyuki Takedani, Kaoru Kitsukawa, Masashi Taki, Akira Ishiguro, Chiai Nagae, Azusa Nagao, Daisuke Nosaka, Yui Kyogoku, Hiroki Oki, Keisuke Iwasaki, Keiji Nogami
Journal: Blood (2023)
Atrial Fibrillation Patients with Immune Thrombocytopenia: A Review of Management Options and Bleeding Risks
Authors: Omar Metwalli, Alaa Rahhal, Ahmed Badr, Raghad Elsherif, Amgad Elshoeibi, Mohamed Elhadary, Basel Elsayed, Awni Alshurafa, Mona Al-Rasheed, Mohamed A Yassin
Journal: Blood (2023)
Reverse Engineering of Antigenic Peptides in LGL to Decipher Disease Triggers
Authors: Arda Durmaz, Carmelo Gurnari, Simona Pagliuca, Colin Hercus, Carlos Bravo-Perez, Luca Guarnera, Nakisha D Williams, Danai Dima, Ishani Nautiyal, Yasuo Kubota, Naomi Kawashima, Jacob Scott, Valeria Visconte, Jaroslaw P. Maciejewski
Journal: Blood (2023)
Retrospective Analysis of Treatment Patterns and Outcomes in Geriatric Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in the Veterans Health Administration (VHA)
Authors: Heidi Latiolais, Supreet Kaur, Michael Mader, Kathleen Franklin, Madison Williams, Ryan Williams, Jean-Pierre Blaize, Amna Naqvi, Snegha Ananth, Michael Meansup Song, Brian Warnecke, Abhishek Pandya, Lakene Raissa Djoufack Djoumessi, Lindsey Lu, Phillip Nazarewicz, Manuel Espinoza-Gutarra, Kana Tai Lucero, Jennifer Whitehead, Alaq Al-Abayechi, Lauren Boyle, Sophia Lee, Gabriel Roman Souza, Esteban Toro Velez, Ian Mines, Zohra Nooruddin
Journal: Blood (2023)
Efficacy and Safety of a Third Generation CD20 CAR-T (MB-106) for Treatment of Relapsed/Refractory Indolent B-Cell Non-Hodgkin Lymphoma: Phase-1 Results from a Multicenter Trial
Authors: Mazyar Shadman, Paolo F. Caimi, Susan M. O'Brien, Patrick M. Reagan, Bruce Dezube, Punya Navaratnarajah, Tripti Gaur, Suzanne Petrossian, Anthony Germani, Brian G Till, Jeremy S. Abramson
Journal: Blood (2023)
SHP2 Inhibition Enhances JAK2 Inhibitor Therapy in Preclinical Models of Myeloproliferative Neoplasms
Authors: Garima Pandey, Lucia Mazzacurati, Nathan P. Horvat, Tegan Rowsell, Narmin E. Amin, Guolin Zhang, Afua Adutwumwa Akuffo, Christelle M. Colin-Leitzinger, Eric B. Haura, Andrew T. Kuykendall, PK Epling-Burnette, Gary W. Reuther
Journal: Blood (2023)
First Results from a Phase 1, First-in-Human Study of the Bruton's Tyrosine Kinase (BTK) Degrader Bgb-16673 in Patients (Pts) with Relapsed or Refractory (R/R) B-Cell Malignancies (BGB-16673-101)
Authors: John F. Seymour, Chan Yoon Cheah, Ricardo Parrondo, Meghan C. Thompson, Don A. Stevens, Masa Lasica, Michael L. Wang, Abhijeet Kumar, Judith Trotman, Maan Alwan, Wei Ding, Kunthel By, Bilal Tariq, Xiangmei Chen, Shannon Fabre, Jason Paik, Amit Agarwal, Constantine S. Tam
Journal: Blood (2023)
Ratio of Circulating CD8 + T Lymphocytes to M-MDSCs (CD8MMR): A Novel Prognostic Predictor for Treatment-Naïve DLBCL Patients
Authors: Hao-Yuan Wang, Fu-Chen Yang, Ching-Fen Yang, Chun-Kuang Tsai, Po-Shen Ko, Yao-Chung Liu, Nien-Jung Chen
Journal: Blood (2023)
Tolerability in Transplant-Ineligible Patients with Newly Diagnosed Acute Myeloid Leukemia Treated with Venetoclax Based Combination Therapy: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials
Authors: Thura Win Htut, Myat Min Han, Ei Moe Phyu, Kyaw Zin Thein
Journal: Blood (2023)
Prognostic Significance of CD30 Expression and Response to Brentuximab Vedotin in Patients with Angioimmunoblastic T Cell Lymphoma
Authors: Alexandra Elias, Mario L. Marques-Piubelli, Ranjit Nair, Rishab Prakash, Sairah Ahmed, Luis Malpica, Hun Ju Lee, Jie Xu, Christopher R. Flowers, Sattva S. Neelapu, Francisco Vega, Roberto Miranda, Swami P. Iyer
Journal: Blood (2023)
Clinical Course of Adult T-Cell Leukemia-Lymphoma with Central Nervous System Involvement
Authors: Takuya Ueno, Makoto Yoshimitsu, Momone Sameshima, Taichi Nagano, Rika Akahoshi, Yusetsu Takeshita, Aya Shodai, Kodai Shima, Naosuke Arima, Maiko Hayashida, Daisuke Nakamura, Kenji Ishitsuka
Journal: Blood (2023)